The report by Haissaguerre et all was very exciting because it demonstrated a new catheter ablation approach for the cure of atrioventricular (AV) nodal reentrant tachycardia while preserving transmission in the intrinsic "sinoventricular conduction system."
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Elimination ofAtrioventricular Nodal Reentrant Tachycardia
The report by Haissaguerre et all was very exciting because it demonstrated a new catheter ablation approach for the cure of atrioventricular (AV) nodal reentrant tachycardia while preserving transmission in the intrinsic "sinoventricular conduction system."
Haissaguerre et AI, however, use the term "P potential" and then provide a detailed description of the P potential without appropriate citation for the origin of this terminology. Although my article2 was cited four times in their report, it is not clearly denoted that I coined the term, described the histological/anatomic substrate, and also provided the first definitive electrophysiological description under various conditions. Of most concern, however, is that Haissaguerre et al's paper is misleading in understanding the physiological and clinical significance of the P potential. They described the P potential as either "They occupied the diastolic interval between atrial and ventricular electrograms" (p. 2163) or "At low-rate stimulation, the slow potentials occupied all (giving a continuum of electrograms) or some of the interval between the atrial and ventricular electrograms" (pp. 2165-2166). This is not the case, as evidenced by their figures.
In reality, the P potential represents depolarization of the proximal AV bundle, which is the common anatomic input to the AV node.3 The P potential occurs only in the interval between depolarization of the atrium or the superior atrionodal bundle (during exposure to 10 mM potassium) and the atrioventricular node electrogram. The proximal AV bundle is also the common electric input to the AV node, because with transection of the proximal AV bundle/AV node connections, the S potential (which represents depolarization of the superior atrionodal bundle) and the P potential discharge sequentially at the sinus rate, but the AV node discharges spontaneously.2 Furthermore, transmission is rapid through the superior atrionodal bundle.2 The superior atrionodal bundle and the most distal region of the proximal AV bundle are analogous (similar in location and histologically) to the left-and right-going components of the AV node described in human hearts by Anderson et a14 as previously cited.3
The P potential has been recorded routinely ( 
Reply
Our study was begun in September 1990 and finished in May 1991. Therefore, it was performed before the publication of Racker's article describing in particular a "P potential" (P for proximal) in dogs. Our report describes in humans what we called "slow potentials." Slow potentials are recordable along the septum from the coronary sinus to the anterior sites (where they are associated with the His bundle potentials), whereas Racker's P potential is confined to the proximal septal region. Throughout our article, we only ever referred to the nonspecific term "slow potentials." In only one instance (Figure 2 , illustrating control patients) is the slow potential labeled "P" (P for potential) because "SP" for slow potential would have been confused with "slow pathway." Therefore, Racker has considered that our "P" in Figure 2 is adjectival, but this is not so. We are more than surprised by Racker's second criticism, because we do not understand the reason for her confusion. It should be clear to any reader that our figures demonstrate clearly identifiable slow potentials, which are marked by arrows. These slow potentials incontestably occupy all (Figures 1 and 6) or some of the time between the atrial and ventricular electrograms.
In her experimental study, Racker's "P potential" always occurs before the atrioventricular node electrogram. In our study, our "slow potentials" can bridge the atrioventricular interval and then may occur or finish after the His bundle electrogram (as evidenced in our Figures 5 and 8) . Therefore, they cannot simply represent only activity of a common electrical input to the AV node. Their anatomic sources are probably both the AV node (for midseptal potentials) and the multiple atrial fibers entering the AV node or coursing around it. This variable origin explains the recording of complex or double slow potentials as shown in the paper of Damato et al (which we indeed mentioned as our Reference 48). Slow potentials probably also have a different functional significance according to their pattern and recording site. Nevertheless, they represent a good marker for guiding slow "pathway" modification/ablation (with few radiofrequency impulses) in patients with AV nodal reentrant tachycardias. In our patients, the absence of distinct electrical activity during the use of the slow pathway in tachycardia could be the ultimate step in the rate-dependent disintegration of slow potentials. With present clinical methods, we are unable to say whether and which potentials really are involved in AV nodal reentry and which ones are only bystanders. 1) Was there any difference in endothelin values in male versus female healthy volunteers?
2) Heart failure patients in group 4 seem different, as the authors point out, not only with respect to sex and age and less severe heart failure, but also with a higher frequency of valvular and congenital heart disease. Accordingly, it would have been particularly appropriate to know what their peripheral venous plasma endothelin values were and whether such differences might explain some of the overlap evident in the other heart failure patients as opposed to the normal subjects depicted in Figure 1 .
3) The authors state that "endothelin concentration did not appear to relate to the level of left ventricular dysfunction." Are specific data on this point available? 4) Although differences in aortic and renal vein endothelin concentrations may reflect renal extraction, they could be an indication of nonspecific extraction across arterial venous circulations generally, as has been previously demonstrated in both endogenous and exogenous vasoactive substances. Again, peripheral venous endothelin concentrations in group 4 would have been helpful in identifying the specificity of this contention. 5) Although the authors suggest that no correlation exists between ANP and endothelin (Figure 4 ), no r value or statistical significance is provided. Arguably, the data could contain a subset of patients in whom the correlation was excellent and others in whom it was not; in this regard, the duration of heart failure, with those of more recent onset being expected to potentially have such a correlation and those with chronic heart failure not, might provide further insight. P In our study* of patients with the Wolff-Parkinson-White (WPW) syndrome undergoing catheter ablation,2 the temperature of the electrode/tissue interface rose rapidly and reached a steady state after only 2-5 seconds. Wittkampf and coworkers recently reported results of an animal study in which thermocouples embedded within the myocardium were used to measure temperature at various distances from the site of ablation.3 They noted a very slow rise in myocardial temperature, with continued increases even after 2 minutes of radiofrequency energy application. On the basis of these differences, Wittkampf concluded that "the rate of rise of interface and myocardial temperature differs with approximately a factor of 60." However, if myocardial temperature rose very slowly during radiofrequency ablation, then progressive electrophysiological effects might be expected with long energy applications. In fact, it is very rare to see progressive electrophysiological effects after about 15 seconds of radiofrequency energy application. A previous study by the same author4 also argues strongly against the notion of slowly progressive heating of the myocardium adjacent to the ablation site. In a careful analysis of the dynamics of lesion formation in vivo, Wittkampf et a14 showed that there was no further increase in lesion size after approximately 20 seconds of radiofrequency energy application. These data are inconsistent with their more recent observations and suggest that tip temperature monitoring is a reasonable reflection of heating in the zone of the lesion.
Our study of temperature monitoring during WPW ablation was notable for marked variability in the efficiency of heating between target sites. As a result, there was no correlation between applied power and steady-state temperature. Wittkampf states that "this conclusion may not be justified" because some high-power applications were interrupted by coagulum formation. Even if these four applications are removed from the analysis, the results are the same. Regardless, the issue is not whether there is no correlation or a weak correlation between power and temperature. The important point is that there are a multitude of variables that can affect heating during ablation and that temperature is a much more accurate index of lesion formation than applied power. Jonathan J. Langberg, MD Cardiology Division University of Michigan Medical Center Ann Arbor, Michigan
